Sonalleve Therapy platform

Sonalleve MR-HIFU

Therapy platform

Najít podobné výrobky

Sonalleve MR-HIFU and Tulsa-pro are Profound products. Please visit the Profound webpages* for more information.

Make the most of each treatment



In the later stages of their disease, many cancer patients develop bone metastases, which can cause severe and debilitating pain. UMC Utrecht is using innovative Sonalleve MR-HIFU therapy to treat non-invasive palliative pain treatment of bone metastases.

Dr. Merel Huisman, radiologist
Professor Maurice van den Bosch, Chairman Department of Radiology & Nuclear Medicine

"With Sonalleve MR-HIFU we have the technique to remove the uterine fibroids without surgery. I think Sonalleve MR-HIFU is a very promising technique because it can be done as an outpatient treatment. This makes good financial sense and patients tolerate it very well".

Professor Klaus Diedrich, director of the Obstetrics and Gynecology Clinic at University Hospital Schleswig-Holstein Lübeck, Germany

"We started to treat our cancer patients for their pain from bone metastasis with the Sonalleve MR-HIFU system. The results had been exciting from the beginning; most of our patients experience a very significant pain relief within a week of having the procedure".

Professor Nandita deSouza, co-director of The Institute of Cancer Research, Sutton, Surrey, UK

"With the new DISC skin cooling of the Sonalleve MR-HIFU system we can treat our fibroid patients much faster than before.* We also started to treat larger fibroids and can now offer this non-invasive option to more patients".

* Difference between Sonalleve MR-HIFU with R3.2 software without DISC and with software R3.5 software and DISC

Professor Markus Zähringer, medical director of the Diagnostic and Interventional Radiology Clinic, Marienhospital, Stuttgart, Germany.
  • *Philips is not responsible for the information shared on third party websites.